CQDM announces funding for three cancer research projects, supported by the Québec government grant. These projects aim to enhance cancer treatment efficacy and reduce side effects. They include Theratechnologies’ platform
This group has been created by SaRC-Q to offer a space for sharing, support, and mutual assistance to all those living with GIST (Gastrointestinal Stromal Tumor) in Quebec and Canada.
Trials involving Tenosynovial Giant Cell Tumor (TGCT) in Canada now welcome participants from all regions across the country. If you would like to participate in these clinical trials, lodging and
Montreal, January 26, 2024 – Driven by an extraordinary spirit, the Harding sisters, Cassandra and Katelyn, have faced the same rare cancer—Osteosarcoma—within months of each other. This rare form of
In a groundbreaking study, researchers led by Vanessa Di Lalla at McGill University have conducted a comprehensive review of Radiation-Induced Sarcomas (RISs) of the breast, offering valuable insights into a
We are thrilled to announce the initiation of two groundbreaking clinical trials, marking significant strides in the field of sarcoma research. These trials, Abbisko Pimicotimib and PEAK, hold promise in
Exciting developments in sarcoma research have brought forth two promising treatments that hold immense potential for transforming the landscape of sarcoma care. SaRC-Q is thrilled to share the latest breakthroughs:
Thanks to the efforts and dedication of our co-founder Dr. Ramy Saleh, McGill enrolled the first patient into the Calgary’s Cart T cell trial for advanced alveolar soft-part sarcoma. SaRC-Q